Next Article in Journal / Special Issue
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
Previous Article in Journal / Special Issue
Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages
Article Menu

Export Article

Open AccessReview
Vaccines 2015, 3(2), 467-489; doi:10.3390/vaccines3020467

The Promise of Preventive Cancer Vaccines

1
Department of Experimental Diagnostic and Specialty Medicine (DIMES), University of Bologna, Viale Filopanti 22, Bologna 40126, Italy
2
Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Via Nizza 52, Torino 10126, Italy
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Mary Lenora (Nora) Disis
Received: 17 April 2015 / Revised: 4 June 2015 / Accepted: 8 June 2015 / Published: 17 June 2015
(This article belongs to the Special Issue Cancer Vaccines)
View Full-Text   |   Download PDF [420 KB, uploaded 17 June 2015]   |  

Abstract

Years of unsuccessful attempts at fighting established tumors with vaccines have taught us all that they are only able to truly impact patient survival when used in a preventive setting, as would normally be the case for traditional vaccines against infectious diseases. While true primary cancer prevention is still but a long-term goal, secondary and tertiary prevention are already in the clinic and providing encouraging results. A combination of immunopreventive cancer strategies and recently approved checkpoint inhibitors is a further promise of forthcoming successful cancer disease control, but prevention will require a considerable reduction of currently reported toxicities. These considerations summed with the increased understanding of tumor antigens allow space for an optimistic view of the future. View Full-Text
Keywords: cancer vaccines; cancer immunoprevention; cancer immunotherapy; Her2; immune checkpoint inhibitors cancer vaccines; cancer immunoprevention; cancer immunotherapy; Her2; immune checkpoint inhibitors
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lollini, P.-L.; Cavallo, F.; Nanni, P.; Quaglino, E. The Promise of Preventive Cancer Vaccines. Vaccines 2015, 3, 467-489.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top